Company intelligence / Profile preview

i(x)l

Ownership: Private
Development stage: Other

Overview

XL Biotec is a leading supplier of laboratory reagents and kits supporting life science research in Thailand. The company partners with over a dozen global suppliers to provide high-quality products for applications such as cell culture, molecular biology, immunology, cancer research, and stem cell studies. It serves universities, hospitals, biotech companies, and biopharmaceutical firms throughout Southeast Asia.

Modalities: Cell cultureMolecular biologyImmunologyCancer researchStem cells
Industry: Non-Drug Biotech

Partnerships

Partners with more than twelve top global reagent suppliers

Beyond the preview

Go deeper on i(x)l.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i(x)l.

Explore the full profile